Table 6.
Parameter | Unit | Fluoxetine group | Multiple dose group A | Multiple dose group B | Multiple dose group C |
---|---|---|---|---|---|
AUC (0–∞) | ug/L∗h | 12.20 ± 2.67 | 11.20 ± 3.86 | 14.54 ± 3.22 | 22.01 ± 4.49a |
MRT (0–t) | h | 7.67 ± 1.02 | 6.82 ± 0.77 | 6.88 ± 0.74 | 10.12 ± 1.11a |
t1/2z | h | 8.95 ± 7.50 | 5.46 ± 0.25 | 4.93 ± 0.34 | 8.34 ± 3.31 |
T max | h | 0.75 | 1 | 1 | 1 |
CLz/F | L/h/kg | 149.29 ± 28.93 | 178.71 ± 55.98 | 130.48 ± 31.64 | 82.49 ± 12.18a |
C max | ug/L | 2.19 | 1.58 | 2.14 | 2.38 |
Fluoxetine group: fluoxetine 1.8 mg/kg·d for consecutive 14 d; multiple dose group A: CSGS 5.9 g/kg·d and fluoxetine 1.8 mg/kg·d for consecutive 14 d; multiple dose group B: CSGS 11.8 g/kg·d and fluoxetine 1.8 mg/kg·d for consecutive 14 d; multiple dose group C: CSGS 23.6 g/kg·d and fluoxetine 1.8 mg/kg·d for consecutive 14 d. aP < 0.05, significantly different from the fluoxetine group.